Article
The emergence of resistance to targeted cancer therapeutics.
Pharmacogenomics - 1 Sept 2002
Mellinghoff Ingo K, Sawyers Charles L
Abstract excerpt
Drug resistance has always been a concern in cancer treatment, often blamed on the genetic complexity and instability of tumor cells. While studies of cancer cell lines have implicated an array of potential mechanisms, it has been difficult to translate these insights into clinically meaningful improvements in cancer treatment. The successful deployment of molecularly targeted therapeutics in some cancers has led...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
